Physician profile
Ben D Johnson
NPI 1720152465
$2,130.94
in general payments reported to CMS, 2019-2025
15 companies · $27.72 in 2025
The $27.72 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $506 · 2022: $678 · 2023: $444 · 2024: $475 · 2025: $27.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.97 | 2021-2024 | |
| Gilead Sciences, INC. | $390.80 | 2023-2024 | Epclusa |
| Astrazeneca Pharmaceuticals LP | $173.18 | 2021-2023 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $138.38 | 2021-2022 | |
| Lilly USA, LLC | $137.16 | 2021-2023 | Jardiance |
| Alkermes, INC. | $99.88 | 2024 | Lybalvi |
| Smith+Nephew, INC. | $94.71 | 2022 | |
| Exact Sciences Corporation | $90.37 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $78.61 | 2021-2024 | Rexulti |
| Novo Nordisk INC | $78.08 | 2022 | |
| Pfizer INC. | $64.34 | 2021 | |
| Alk-Abello, INC | $56.54 | 2024 | Ragwitek, Odactra, Grastek |
| Sanofi-Aventis U.S. LLC | $29.71 | 2022 | |
| Abbott Laboratories | $20.03 | 2023 | Cardiomems |
| Glaxosmithkline, LLC. | $18.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.